Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04018638 · ClinicalTrials.gov registry record · NA

Blood-Flow Restriction Exercise Following a Knee Replacement

A NA study of Knee Osteoarthritis and Knee Injuries, sponsored by Michigan Technological University.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT04018638 is a NA study of Knee Osteoarthritis and Knee Injuries that is active but no longer recruiting, run by Michigan Technological University. The registered enrollment target is 30 participants, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04018638, a NA study of Knee Osteoarthritis and Knee Injuries, is active but no longer recruiting, sponsored by Michigan Technological University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study will determine the safety and efficacy of using blood-flow restriction exercise enhancement (B-FREE) to overcome persistent quadriceps muscle weakness that occurs following a total knee replacement (TKR).

Interventions

  • OTHER B-FREE

Study Locations (1)

Michigan

  • Michigan Technological University - Houghton

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2019-06-25
Est. Completion 2025-12-25
Phase NA

What the Registry Record Tells You About NCT04018638

The ClinicalTrials.gov registry entry for NCT04018638 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (90% lower). The listed sponsor is Michigan Technological University, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Knee Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which B-FREE is the first listed.

NCT04018638 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT04018638 about?

NCT04018638 is a clinical study titled "Blood-Flow Restriction Exercise Following a Knee Replacement". This study will determine the safety and efficacy of using blood-flow restriction exercise enhancement (B-FREE) to overcome persistent quadriceps muscle weakness that occurs following a total knee replacement (TKR).

What is the current status of trial NCT04018638?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2019-06-25. Estimated completion is 2025-12-25.

What conditions does trial NCT04018638 study?

This clinical trial studies the following conditions: Knee Osteoarthritis, Knee Injuries, Knee Arthritis.

What interventions are being tested in trial NCT04018638?

The interventions under investigation include: B-FREE (OTHER).

Who is sponsoring clinical trial NCT04018638?

This trial is sponsored by Michigan Technological University, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04018638 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Knee Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.